Owens & Minor, Inc. Common Stock (OMI)
9.9600
+0.2500 (2.57%)
Owens & Minor is a global healthcare logistics company that specializes in the distribution of medical supplies and products to hospitals, healthcare providers, and other organizations within the healthcare industry
The company provides a range of services, including inventory management, supply chain solutions, and the development of customized healthcare products, ensuring that healthcare providers have timely access to the essential medical items needed to deliver quality patient care. By leveraging technology and comprehensive logistics capabilities, Owens & Minor aims to enhance the efficiency of healthcare operations and improve overall patient outcomes.

Shares of medical supply and logistics company Owens & Minor (NYSEOMI) jumped 36.9% in the afternoon session after the company reported impressive fourth quarter 2024 results, exceeding analysts' EBITDA and EPS expectations despite delivering in-line revenue. Full-year revenue guidance was also in line, which is comforting. On the other hand, its full-year EPS guidance fell short of Wall Street's estimates. Overall, the quarter was solid, with strong revenue growth, improving margins, and positive guidance.
Via StockStory · February 28, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · February 28, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · February 28, 2025

Medical supply and logistics company Owens & Minor (NYSEOMI) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.5% year on year to $2.70 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $11 billion at the midpoint. Its non-GAAP profit of $0.55 per share was 5.7% above analysts’ consensus estimates.
Via StockStory · February 28, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via Chartmill · February 28, 2025

Owens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting double-digit adjusted EBITDA growth.
Via Benzinga · February 28, 2025

U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000.
Via Benzinga · February 28, 2025

Medical supply and logistics company Owens & Minor (NYSEOMI) will be reporting earnings tomorrow morning. Here’s what to expect.
Via StockStory · February 27, 2025

Via Benzinga · February 28, 2025

Via Benzinga · February 28, 2025

Shareholders of Owens & Minor would probably like to forget the past six months even happened. The stock has dropped 49.9% and now trades at a new 52-week low of $7.77. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · February 14, 2025

U.S. stock futures were trading lower on Tuesday after Monday's decline as the new administration tariffs continued to spook the market.
Via Benzinga · February 4, 2025

Via Benzinga · February 4, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · February 3, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 3, 2025

Stocks are lower midday, but have pared much steeper premarket losses, after U.S. President Trump paused tariffs on Mexico for one month.
Via Talk Markets · February 3, 2025

Via Benzinga · February 3, 2025

Owens & Minor shares dipped after disclosing preliminary results and financing for the Rotech Healthcare Holdings, Inc. buyout. The company expects to close the deal in the first half of 2025 and sees significant synergy opportunities. Preliminary results for Q4 and 2024 were also provided.
Via Benzinga · February 3, 2025

Via Benzinga · November 5, 2024

Owens & Minor Q3 2024 highlights include a 5% sales increase to $2.72 billion, adjusted EPS of $0.42, and Patient Direct revenue growth led by diabetes and sleep supplies.
Via Benzinga · November 4, 2024

Cardinal Health Inc. is one of the leading wholesale distributors of pharmaceuticals, medical/surgical supplies and related products to a broad range of health care customers.
Via Talk Markets · September 13, 2024

OMI stock results show that Owens & Minor beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 2, 2024